TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline Volume from hard palate to the base of epiglottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Cross section area on the tip of epiglottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-hour mean diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure changes during tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy on the Tower of London Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Net Change on NIH Stroke Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Geometric Mean Titers (GMTs) of Serum Hemagglutination Inhibition (HAI) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Titers (GMTs) of Serum Neutralizing (Neut) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving Hemagglutination Inhibition (HAI) Antibodies Titer of 1:40 or Greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Suture characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pay period work relative value-based provider efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: behavioral performance (e.g., reaction time, accuracy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMS evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MRI activation (BOLD response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Adverse Drug Reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Progression Free Survival (PFS) at Six Months
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Self-reported Caregiver Strain
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Difference in Health Insurance Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in Health Insurance Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in Confidence Communicating About Health Care Costs With Physician
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: catalase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma malondialdehyde level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep architecture in preterm infants
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in Ultrasound image of upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical activity (objective measurement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical activity (subjective measurement)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Degree of secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of mastectomy skin flap necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: dapivirine concentration in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy issues rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Delivery issues rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: % of preterm children with a failure to thrive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood cell biomarkers for diagnosis of Alzheimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Outcome of STEMI patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retinal microstructure using OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vasculature by optical coherence tomography angiography (OCTA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with union after transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Peak Positive Subjective Responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy Measured as Percentage of Time Spent in Optimal Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Measured as Percentage of Time Spent in Sub-optimal Range
Endpoint domain: Adverse events/effects
Primary endpoint: Number of surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Little's irregularity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: subjective rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neurocognitive assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Discontinuation rate of palliative sedation
Endpoint domain: Adverse events/effects
Primary endpoint: Complete response rate of palliative sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mouth opening in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Breastfeeding at 6 Months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Lactogenesis Stage II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility determined by accrual
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility determined by adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility determined by patient retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first response to TOF stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Days Abstinent From Cocaine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical activity of the lower and upper extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Respiratory Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pocked depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AAA stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failure-free survival (TFFS)
Endpoint domain: Mortality/survival
Primary endpoint: Pituitary Response to GnRH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adherence to prescribed behavioral assignment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menorrhagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Small-bowel cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cardiac Medication Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: EORTC C-30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EOS-18
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Neurological Test Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tumor SUV value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of hepatotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Healing Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of HSP70 exosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean ambulatory 24-hour systolic blood pressure change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Joint mobility of both knees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative laxity in varus, valgus, anterior and posterior drawer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharmacokinetic parameters of lorcaserin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Incidence of Reported Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Incidence of Explantation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced Severe OLE-Emergent AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of Doxycycline in relapsed CTCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Iowa Gambling Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Bedwetting Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weekly average of daily pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in psychological flexibility
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in jump performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of CD4 T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prosthetic Fit and Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut Dysbiosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Glycated hemoglobin HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life score (DQOL score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of hypoglycemic episodes (<70 mg/dl)
Endpoint domain: Adverse events/effects
Primary endpoint: Total opioid consumption (oral morphine equivalents) in the first 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid consumption (oral morphine equivalents) in the second 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale (VAS) pain score at 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale (VAS) pain score at 48 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimental State Examination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-ferumoxytol enhancement on Brain MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Physical Global Assessment (PGA)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Influx of inflammatory cells in the lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection of hot spots on a foot thermal map image
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anatomo-pathological changes of the endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Histochemical changes of the endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Transcriptional changes of the endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Water homeostasis changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Oral Health Impact Profile for TMD summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Malondialdehyde levels in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein Carbonyl levels in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of total antioxidant capacity levels in gingival crevicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of entering the critical stage
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to educational programme
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Skeletal muscle proteome signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonsurgical Resolution of Focal Vitreomacular Traction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Percentage of Participants With Undetectable HIV-1 RNA Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Extremity Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pinch Grip Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Rejection of failed allograft
Endpoint domain: Adverse events/effects
Primary endpoint: Best Overall Response rate using RECIST criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 14-Week Progression-Free Survival (PFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Severe valve dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Auditory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytokines and chemokines expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients with recurrent or refractory tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pharmacokinetic Parameter Estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure (COP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4 Cells normal value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Viral load undetectable (<50 per ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Any early adverse effects due to drug interactions
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rates of spontaneously reported hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of irrigation fluid used during ureteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgeon's rating of ureteroscopic visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of grounding days from flying due to neck pain
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Baseline Level of Engagement in Care--Appointments in the Past Six Months
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change from Baseline Level of Engagement in Care--Future Appointments
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Overall tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: raltegravir concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Utility Index (CUI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stimulatory autoantibodies to the PDGF receptor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Asthma Impact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction With Participation in Social Roles
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of patients with treatment-related adverse effects on thyroid function
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change From Baseline in Mean Wall Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Target (Plaque) to Background (Blood) Ratio From an Index Vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Food diaries
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent reports
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency and severity of moderate to severe hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of fatigue or malaise
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Yearly Event Rate for Composite Endpoint of Stroke, Transient Ischaemic Attacks, System Thromboembolism, Myocardial Infarction, Other Major Adverse Cardiac Events and Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Yearly Event Rate for Major Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Differential gene expression in intraocular disease tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically Significant Change From Baseline in Body Weight at End of Study Visit (EOSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eastern Cooperative Oncology Group (ECOG) Performance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a total home smoking ban
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change From Baseline in the International Restless Legs Syndrome Rating Scale (IRLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Classified as Responders to Treatment on the Investigator-rated Clinical Global Impressions of Improvement (CGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maternal Plasmodium infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in the Common Terminology Criteria for Adverse Events CTCAE 5.0 toxicity table score
Endpoint domain: Adverse events/effects
Primary endpoint: Composite Score for Post-Operative Recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Blood glucose measurement results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood flow measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Correct Responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Incorrect Responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Distribution of topotecan in tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of participants reporting serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed COVID-19 in Phase 2/3 participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prematurity
Endpoint domain: Mortality/survival
Primary endpoint: Difference in VAS score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Global renal perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean Individual Component of TSS of Rhinorrhoea, Nasal Congestion and Post-nasal Drip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Operative and Post-operative Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving Plasma HIV-1 RNA <50 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes